Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Opeyemi Jegede"'
Autor:
Victoria Shelton, Rajesh Detroja, Ting Liu, Keren Isaev, Anjali Silva, Verena Passerini, Mehran Bakhtiari, Lourdes Calvente, Michael Hong, Michael Y. He, Saloni Modi, Samantha A. Hershenfeld, Maja Ludvigsen, Charlotte Madsen, Stephen Hamilton-Dutoit, Francesco Annibale d’Amore, Marianne Brodtkorb, Nathalie A. Johnson, Tara Baetz, David LeBrun, Josh W. D. Tobin, Maher K. Gandhi, Andrew J. Mungall, Wei Xu, Susana Ben-Neriah, Christian Steidl, Jan Delabie, Rosemarie Tremblay-LeMay, Opeyemi Jegede, Oliver Weigert, Brad Kahl, Andrew M. Evens, Robert Kridel
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Follicular lymphoma (FL) exhibits considerable variability in biological features and clinical trajectories across patients. To dissect the diversity of FL, we utilized a Bernoulli mixture model to identify genetic subtypes in 713 pre-treatm
Externí odkaz:
https://doaj.org/article/34d7cb757e0c4fbe916aa9cea2b4742d
Autor:
Obiora Egbuche, Temidayo Abe, Shirley I. Nwokike, Opeyemi Jegede, Kenechukwu Mezue, Titilope Olanipekun, Ifeoma Onuorah, Melvin R. Echols
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 22, Iss 4, Pp 1667-1675 (2021)
In-hospital acute kidney injury (IH-AKI) has been reported in a significant proportion of patients with COVID-19 and is associated with increased disease burden and poor outcomes. However, the mechanisms of injury are not fully understood. We sought
Externí odkaz:
https://doaj.org/article/98b3c16449d14bc2975810adceb42c1f
Autor:
Apollos Daniel, Nuhu Abubakar Garba, Ibrahim Ahmadu, Muhammad Shakur Abubakar, Opeyemi Jegede Yejide, Patience Obiagwu, Mustafa O Asani, Ibrahim Aliyu
Publikováno v:
Medical Journal of Dr. D.Y. Patil Vidyapeeth, Vol 15, Iss 1, Pp 115-117 (2022)
Levamisole-induced thrombocytopenia and vasculitis are rare entities in children. Here, we report a 5-year-old male who presented with complaints of purpuric rashes and nasal and gum bleeding for 24 h following intake of single high-dose levamisole f
Externí odkaz:
https://doaj.org/article/6731365cc3824a2d9e75812c345cf8a0
Autor:
Catherine Diefenbach, Opeyemi Jegede, Richard Ambinder, Jonathon Cohen, Michael Robertson, Kevin David, Ranjana Advani, Timothy Fenske, Stefan Barta, Neil Palmisiano, Jakub Svoboda, David Morgan, Reem Karmali, Brad Kahl, Stephen M. Ansell
Publikováno v:
HemaSphere, Vol 6, Pp 46-47 (2022)
Externí odkaz:
https://doaj.org/article/747d3fe7b84b48909dc89cf4beb50fee
Autor:
Temidayo Abe, Obiora Egbuche, Joseph Igwe, Opeyemi Jegede, Bivek Wagle, Titilope Olanipekun, Anekwe Onwuanyi
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 2, Pp n/a-n/a (2021)
Abstract Introduction Coronavirus disease 2019 (COVID‐19) has become a major global crisis. Preliminary reports have, in general, indicated worse outcomes in diabetes mellitus (DM) patients, but the magnitude of cardiovascular (CV) complications in
Externí odkaz:
https://doaj.org/article/c394e39191234c9299ed038a23501478
Autor:
Stephen L. Graziano, Joan H. Schiller, Charles A. Butts, Conor E. Steuer, Steven M. Keller, Suresh S. Ramalingam, Opeyemi Jegede, Alex A. Adjei, William J. Tester, David R. Gandara, Heather A. Wakelee, Suzanne E. Dahlberg
Publikováno v:
J Thorac Oncol
Introduction Smoking cessation has been reported to benefit patients even after a diagnosis of lung cancer. We studied the smoking behavior of patients who participated in a phase 3 trial of adjuvant therapy following resection of stages IB–IIIA NS
Autor:
Jonathon B. Cohen, Opeyemi Jegede, Craig A. Portell, Mehdi Hamadani, Catherine S. Diefenbach, Kevin A. David, Christopher D. Fletcher, Daniel J. Landsburg, Suparna Mantha, Brad S. Kahl
Publikováno v:
Blood. 140:6487-6488
Autor:
Michael B. Atkins, Opeyemi Jegede, David F. McDermott, Naomi B. Haas, Mehmet Asim Bilen, Mark N. Stein, Jeffrey A. Sosman, Elizabeth R. Plimack, Robert S. Alter, Moshe Chaim Ornstein, Michael E. Hurwitz, David J. Peace, David Johnson Einstein, Paul J. Catalano, Hans J. Hammers, Meredith M. Regan
Publikováno v:
Journal of Clinical Oncology. 41:604-604
604 Background: Treatment with immunotherapy can be associated with prolonged disease control after discontinuation without the need for further anticancer therapy. Toxicity from therapy can also persist after cessation. TFS with and without toxicity
Autor:
David A. Braun, Kelly Street, Opeyemi Jegede, Neil Ruthen, Miya Hugaboom, Nicholas R Schindler, David F. McDermott, Elizabeth R. Plimack, Jeffrey A. Sosman, Naomi B. Haas, Michael E. Hurwitz, Hans J. Hammers, Sabina Signoretti, Michael B. Atkins, Catherine J. Wu
Publikováno v:
Journal of Clinical Oncology. 41:698-698
698 Background: Nivolumab (nivo) monotherapy demonstrated anti-tumor activity in treatment-naïve renal cell carcinoma (RCC) in Part A of HCRN GU16-260 across all IMDC groups and in multiple histologies. Patient tumor samples were collected to charac
Autor:
David Avigan, Martin S. Tallman, Mark R. Litzow, Kellie Sprague, Francine M. Foss, Henry N. Wagner, Xin Victoria Wang, Roger Strair, Sandra J. Horning, William J. Hogan, Randall D. Gascoyne, Opeyemi Jegede, Theresa L. Whiteside, Selina M. Luger, Daniel A. Arber, Hillard M. Lazarus, Edward A. Stadtmauer, Kenneth B. Miller
Publikováno v:
Transfusion
Background Extracorporeal photopheresis (ECP) is an immunomodulatory cellular therapy which has been shown to induce a tolerogenic state in patients with acute and chronic graft-vs-host disease. ECOG-ACRIN explored the activity of ECP as a part of a